May 2020 FDA Recall Doxycycline by American Health Packaging (D-1293-2020 - Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).)

This Class II drug recall was voluntarily initiated by American Health Packaging on May 19, 2020 for the product Doxycycline. The FDA reported the reason for recall as failed dissolution specification - dissolution results of 59% (spec. nlt 85%) at the 24 month time point (end of shelf life).. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1293-2020

Reason for Recall
Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).
Initiated
05-19-2020
Reported
06-17-2020
Quantity
15,755 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
American Health Packaging
Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC Carton 62584-693-21; NDC Unit Dose 62584-693-11

Batch or Lot Expiration Information

Lot# Lots 179605, Exp 06/30/2020; 181105, Exp 08/31/2020; 183019, Exp 01/31/2021

Affected Packages Involved in this Recall